FDA Inspection
Kang Zhang, M.D., Ph.D.Kang Zhang, M.D., Ph.D. – FDA Inspection, Aug 1, 2016
Record Details
This FDA Inspection record concerns Kang Zhang, M.D., Ph.D., with an inspection on August 1, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Kang Zhang, M.D., Ph.D.
- Inspection Date
- August 1, 2016
- Product Type
- Drugs
View Company Profile
ID · 54014916-946c-40eb-82de-2decdca6d6d9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 981967
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
7- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Initial and continuing review
- 21 CFR 312.56(a)Monitoring investigations
- 21 CFR 312.56(c)Annual report
- 21 CFR 312.62(a)Accountability records
- 21 CFR 312.62(c)Record retention
- 21 CFR 50.25(c)ClincialTrials.gov statement
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.